251 related articles for article (PubMed ID: 17031633)
1. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
3. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
[TBL] [Abstract][Full Text] [Related]
7. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
[TBL] [Abstract][Full Text] [Related]
8. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
9. Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade.
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Dec; 55(10):1270-7. PubMed ID: 24316663
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
11. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
[TBL] [Abstract][Full Text] [Related]
12. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.
Bajpai J; Gamnagatti S; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Safaya R; Bakhshi S
Pediatr Radiol; 2011 Apr; 41(4):441-50. PubMed ID: 20978754
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.
Thoeny HC; De Keyzer F; Chen F; Ni Y; Landuyt W; Verbeken EK; Bosmans H; Marchal G; Hermans R
Radiology; 2005 Mar; 234(3):756-64. PubMed ID: 15734932
[TBL] [Abstract][Full Text] [Related]
14. An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T
Rogers HJ; Verhagen MV; Shelmerdine SC; Clark CA; Hales PW
Eur Radiol; 2019 Aug; 29(8):4141-4149. PubMed ID: 30560365
[TBL] [Abstract][Full Text] [Related]
15. Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.
Littooij AS; Humphries PD; Olsen ØE
Pediatr Radiol; 2015 Oct; 45(11):1651-60. PubMed ID: 25951925
[TBL] [Abstract][Full Text] [Related]
16. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.
Hayashida Y; Yakushiji T; Awai K; Katahira K; Nakayama Y; Shimomura O; Kitajima M; Hirai T; Yamashita Y; Mizuta H
Eur Radiol; 2006 Dec; 16(12):2637-43. PubMed ID: 16909220
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents.
Alsharief AN; Martinez-Rios C; Hopyan S; Amirabadi A; Doria AS; Greer MC
Pediatr Radiol; 2019 Aug; 49(9):1201-1208. PubMed ID: 31203404
[TBL] [Abstract][Full Text] [Related]
18. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Hanna SL; Parham DM; Fairclough DL; Meyer WH; Le AH; Fletcher BD
Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-sensitized ophthalmic magnetic resonance imaging free of geometric distortion at 3.0 and 7.0 T: a feasibility study in healthy subjects and patients with intraocular masses.
Paul K; Graessl A; Rieger J; Lysiak D; Huelnhagen T; Winter L; Heidemann R; Lindner T; Hadlich S; Zimpfer A; Pohlmann A; Endemann B; Krüger PC; Langner S; Stachs O; Niendorf T
Invest Radiol; 2015 May; 50(5):309-21. PubMed ID: 25612144
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
de Baere T; Vanel D; Shapeero LG; Charpentier A; Terrier P; di Paola M
Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
